William Dull

William Dull has worked in various roles in the healthcare industry since 2009. William began their career at Cytovance Biologics as the Senior Vice President of Sales, Marketing, and Business Development. From 2011 to 2016, they held the position of Regional Business Director at Chelsea Therapeutics, National Sales Director at Aegerion Pharmaceuticals, and Chief Commercial Officer at Renovia Inc. In 2016, they joined Bluffworks as an Investor/Advisor, and in 2019 they became a Member of the Board of Advisors at Petriss. In 2021, they were appointed as the Chief Operating Officer at BiotechExec and the Chief Executive Officer at InnoMed Infertility Division.

William Dull obtained a Bachelor of Business Administration (BBA) from Georgia State University, with a field of study in Business, Management, Marketing, and Related Support Services.